We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epigenetics and Drug Discovery

Article   Jul 27, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
Epigenetics and Drug Discovery
 
 
 

RELATED ARTICLES

Pluripotent Stem Cells in Drug Discovery: Can We Stem the Tide of Unsuccessful Drugs?

Article

Stem cells were first discovered in human cord blood in 1978. Why would we think they can be of more help now? This article delves into reasons behind the sudden interest in stem cells, and highlights how they can be used to advance drug discovery.

READ MORE

How Genomics is Shaping Advanced Therapeutics

Article

Genomics technologies are guiding the development of advanced therapy medicinal products, i.e. gene-based, cell-based, and tissue-engineered approaches. This article highlights the progress, challenges and impact of this interdisciplinary branch of medicine.

READ MORE

Overcoming the Identification Bottleneck in Untargeted Metabolomics: Combining Technological and Software Innovations

Article

Untargeted metabolomics approaches are allowing previously unreported insights into the pathogenesis of disease. However, identifying the large numbers of unknown and structurally diverse metabolites typically present in biological samples has proven to be a major bottleneck. Fortunately, recent advances in technology and software are helping to overcome this challenge.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE